CytomX Therapeutics, Inc. (CTMX)

NASDAQ: CTMX · Real-Time Price · USD

2.130

+1.202 (129.43%)

At close: May 12, 2025, 4:00 PM

2.000

-0.130 (-6.10%)

Pre-market: May 13, 2025, 5:58 AM EDT

CytomX Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	147.56	138.1	101.21	53.16	37.31	68.43	Upgrade
Revenue Growth (YoY)	23.81%	36.45%	90.38%	42.48%	-45.47%	154.36%	Upgrade
Gross Profit	147.56	138.1	101.21	53.16	37.31	68.43	Upgrade
Selling, General & Admin	31.4	29.73	30.02	40.45	39.16	36.03	Upgrade
Research & Development	80.2	83.38	77.68	106.55	114.19	112.94	Upgrade
Operating Expenses	111.6	113.11	107.7	147	153.35	148.97	Upgrade
Operating Income	35.96	25	-6.48	-93.84	-116.04	-80.54	Upgrade
Interest & Investment Income	5.9	7.14	9.84	1.68	0.26	1.84	Upgrade
Currency Exchange Gain (Loss)	-0.04	-0.04	-0.03	0.34	-0.08	-0.03	Upgrade
Other Non Operating Income (Expenses)	0.02	-	-	-	-	-	Upgrade
EBT Excluding Unusual Items	41.84	32.09	3.32	-91.82	-115.87	-78.73	Upgrade
Merger & Restructuring Charges	-	-	-	-7.5	-	-	Upgrade
Pretax Income	41.84	32.09	3.32	-99.32	-115.87	-78.73	Upgrade
Income Tax Expense	0.24	0.22	3.89	-	-	-13.91	Upgrade
Net Income	41.6	31.87	-0.57	-99.32	-115.87	-64.82	Upgrade
Net Income to Common	41.6	31.87	-0.57	-99.32	-115.87	-64.82	Upgrade
Shares Outstanding (Basic)	86	84	74	66	64	46	Upgrade
Shares Outstanding (Diluted)	86	85	74	66	64	46	Upgrade
Shares Change (YoY)	10.23%	14.82%	12.27%	2.48%	39.01%	1.79%	Upgrade
EPS (Basic)	0.49	0.38	-0.01	-1.51	-1.81	-1.40	Upgrade
EPS (Diluted)	0.49	0.38	-0.01	-1.51	-1.81	-1.40	Upgrade
Free Cash Flow	-81.54	-86.54	-56.88	-112.53	-120.64	2.95	Upgrade
Free Cash Flow Per Share	-0.95	-1.02	-0.77	-1.71	-1.88	0.06	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	24.37%	18.10%	-6.41%	-176.50%	-311.00%	-117.70%	Upgrade
Profit Margin	28.19%	23.08%	-0.56%	-186.82%	-310.54%	-94.73%	Upgrade
Free Cash Flow Margin	-55.26%	-62.66%	-56.19%	-211.67%	-323.33%	4.31%	Upgrade
EBITDA	37.65	26.76	-4.31	-91.39	-113.34	-77.97	Upgrade
EBITDA Margin	25.51%	19.38%	-4.26%	-171.91%	-	-113.94%	Upgrade
D&A For EBITDA	1.69	1.77	2.18	2.44	2.71	2.57	Upgrade
EBIT	35.96	25	-6.48	-93.84	-116.04	-80.54	Upgrade
EBIT Margin	24.37%	18.10%	-6.41%	-176.50%	-	-117.70%	Upgrade
Effective Tax Rate	0.57%	0.70%	117.12%	-	-	-	Upgrade

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q